C. Neuchrist et al., Vascular endothelial growth factor (VEGF) and microvessel density in squamous cell carcinomas of the larynx: an immunohistochemical study, ACT OTO-LAR, 119(6), 1999, pp. 732-738
The distribution of vascular endothelial growth factor (VEGF), one of the m
ost important angiogenic factors, and microvessel density (MVD) were assess
ed in laryngeal carcinomas by means of immunohistochemistry. Correlation of
VEGF with MVD and clinical parameters (T stage, N stage, histological grad
ing, survival, recurrence-free interval) was also examined. VEGF expression
was evaluated semi-quantitatively and was observed in varying intensity (i
) in tumour cells, (ii) in the stromal department as diffuse, sometimes str
ong reactivity, especially in close proximity Id tumour masses and (iii) in
macrophages and endothelial cells. Normal epithelium presented no VEGF rea
ctivity except in the immediate vicinity of tumour transformation. Forty pe
rcent of our specimens exhibited substantial VEGF reactivity, whereas 20% s
howed no staining in tumour cells and stroma. high-graded carcinomas reveal
ed higher VEGF expression, but there was no association of tumour Stage or
lymph node status with VEGF or MVD. There was a trend in the survival and r
ecurrence analysis towards a higher risk of disease relapse and shorter Sur
vival time for patients with enhanced VEGF expression. Apart from tumour ce
lls, macrophages seem to be a substantial sourer of VEGF in carcinomas. Thi
s observation supports the concept of a pivotal role of these cells in tumo
ur defence-in our case, promoting tumour formation by contributing to neova
scularization. VEGF was also found in the connective tissue, where it seems
to be bound on collagens and probably builds a reservoir for rapid enzymat
ic mobilization.